Drugs / Inactivated Polio vaccine (Sabin strains)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05457946 Comparator | Jul 2018 → Feb 2019 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | LG Chem | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Polio vaccine (Sabin strains) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05457946 ↗ |
| Modality | Vaccine | “Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)” NCT05457946 ↗ |
| Route | Intramuscular | “Injection within the muscle into the front area of the thigh” NCT05457946 ↗ |